Maintelyte

Magnesium chloride hexahydrate, the active ingredient in Maintelyte, is an electrolyte solution presented as a sterile solution for intravenous injection use. It restores electrolyte balance and fluid volume in patients with electrolyte depletion, hypomagnesemia, hypokalemia, hyponatremia, and supports fluid replacement.

GNH USA supplies Maintelyte as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Maintelyte is an intravenous electrolyte solution used to correct electrolyte disturbances and support fluid balance. - Electrolyte depletion: restores lost electrolytes and fluid volume. - Hypomagnesemia: raises serum magnesium levels to normal range. - Hypokalemia: provides potassium to correct low serum potassium. - Hyponatremia: supplies sodium to normalize serum sodium concentration. - Fluid replacement: contributes to overall intravascular volume restoration.

Adverse reactions to Maintelyte may occur following intravenous administration.

Common Side Effects: - Injection site pain: mild discomfort at the infusion site. - Transient hypermagnesemia: temporary elevation of serum magnesium. - Transient hyperkalemia: temporary rise in serum potassium. - Nausea: mild gastrointestinal upset. - Headache: occasional mild headache. - Mild erythema: slight redness around the injection site.

Serious or Rare Side Effects: - Severe hypermagnesemia: can lead to respiratory depression or cardiac arrest. - Severe hyperkalemia: may cause life‑threatening cardiac arrhythmias. - Anaphylactic reaction: rare but can be life‑threatening. - Cardiac arrhythmia: abnormal heart rhythm due to electrolyte imbalance. - Hypotension: sudden drop in blood pressure. - Metabolic acidosis: rare disturbance of acid‑base balance.

When using Maintelyte, clinicians should consider several safety measures. - Renal impairment: monitor serum electrolytes and adjust infusion rate. - Cardiac disease: avoid rapid infusion in patients with conduction abnormalities. - Pregnancy: use only if clearly needed; limited data are available. - Concurrent electrolyte supplements: assess for additive effects. - Infusion rate: administer under medical supervision to prevent fluid overload. - Store at ambient temperature: keep in original container, protect from light and moisture.

Maintelyte may interact with other medicines; awareness of the interaction level is essential.

Major Interactions (Avoid): - Calcium gluconate: may precipitate magnesium salts. - Loop diuretics: can exacerbate electrolyte shifts. - ACE inhibitors: increase risk of hyperkalemia.

Moderate Interactions (Monitor Closely): - Beta‑blockers: monitor cardiac rhythm. - NSAIDs: may affect renal handling of electrolytes. - Antacids containing aluminum or magnesium: assess cumulative electrolyte load.